Quarterly ResultAug 7, 2026, 04:39 PM
Agenus Reports Q2 Net Loss, YTD Net Income; Raises $176M, Faces Going Concern
AI Summary
Agenus reported a net loss of $0.6 million for Q2 2026 but achieved a net income of $38.6 million for the six months ended June 30, 2026, a significant improvement from a $53.3 million net loss in the prior year period. The company materially strengthened its liquidity, with cash and cash equivalents increasing to $18.7 million from $3.0 million at year-end 2025, driven by $91.0 million from Zydus agreements and $85.0 million upfront gross proceeds from a private placement. Despite these capital raises and improved financial performance, management noted substantial doubt about the company's ability to continue as a going concern for at least one year.
Key Highlights
- Reported net income of $38.6 million for the six months ended June 30, 2026, compared to a $53.3 million net loss in prior year.
- Cash and cash equivalents increased to $18.7 million as of June 30, 2026, from $3.0 million at December 31, 2025.
- Received $91.0 million consideration from Zydus agreements, significantly strengthening liquidity.
- Secured $85.0 million upfront gross proceeds from a private placement.
- Management expressed substantial doubt about the company's ability to continue as a going concern for at least one year.
- Total revenues for the six months ended June 30, 2026, were $68.3 million, up from $49.8 million in 2025.
- Research and development expenses decreased to $26.6 million for the six months ended June 30, 2026, from $48.2 million in 2025.
Price Impact
More from AGEN